These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3102636)

  • 21. [Chronic osteomyelitis due to Pseudomonas aeruginosa: treatment with elastomeric infusor in an outpatient setting].
    Carrega G; Bartolacci V; Burastero G; Casalino Finocchio G; Izzo M; Ronca A; Santoriello L; Tigano S; Riccio G
    Infez Med; 2011 Dec; 19(4):257-61. PubMed ID: 22212166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa sacroiliitis and osteomyelitis of pelvic bones after radical prostatectomy.
    Andonian S; Rabah DM; Aprikian AG
    Urology; 2002 Oct; 60(4):698. PubMed ID: 12385945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa infections in the podiatric patient.
    Le Frock JL; Ristuccia AM
    Clin Podiatr Med Surg; 1990 Jul; 7(3):493-500. PubMed ID: 2119248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report.
    Conde-Díaz C; Llenas-García J; Parra Grande M; Terol Esclapez G; Masiá M; Gutiérrez F
    J Med Case Rep; 2017 Feb; 11(1):48. PubMed ID: 28219414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Trend of therapy in Pseudomonas aeruginosa infections].
    Jannuzzi C; Tassara A
    G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.
    Krajewski J; Bode-Böger SM; Tröger U; Martens-Lobenhoffer J; Mulrooney T; Mittelstädt H; Russlies M; Kirchner R; Knobloch JK
    Int J Antimicrob Agents; 2014 Oct; 44(4):363-6. PubMed ID: 25182711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of colistin in a 8-year-old child with acute bone infection.
    Magréault S; Petyt C; Senneville E; Fron D; Nectoux E; Loiez C; Marchand S; Grégoire N; Couet W
    Clin Microbiol Infect; 2018 Sep; 24(9):1025-1026. PubMed ID: 29723571
    [No Abstract]   [Full Text] [Related]  

  • 29. Lumbar osteomyelitis with Pseudomonas.
    Sabir N; Rafi S; Hashmi I; Farooqi BJ
    J Pak Med Assoc; 2007 Oct; 57(10):517-8. PubMed ID: 17990430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced bacterial uptake and bactericidal properties of ofloxacin loaded on bioadhesive hydrogels against Pseudomonas aeruginosa.
    Romero VL; Manzo RH; Alovero FL
    J Chemother; 2010 Oct; 22(5):328-34. PubMed ID: 21123156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of antimicrobial agents. Lividomycin].
    Fukaya K; Kitamoto O
    Jpn J Antibiot; 1972 Dec; 25(6):375-9. PubMed ID: 4353341
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of ofloxacin on mice challenged by ofloxacin-resistant Mycobacterium bovis strains].
    Tsukamura M
    Kekkaku; 1987 Apr; 62(4):235-8. PubMed ID: 3306084
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
    Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
    Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin.
    Kanellakopoulou K; Thivaios GC; Kolia M; Dontas I; Nakopoulou L; Dounis E; Giamarellos-Bourboulis EJ; Andreopoulos A; Karagiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2335-9. PubMed ID: 18411320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental pseudomonas osteomyelitis: treatment with sisomicin and carbenicillin.
    Van Wingerden GI; Lolans V; Jackson GG
    J Bone Joint Surg Am; 1974 Oct; 56(7):1452-8. PubMed ID: 4215436
    [No Abstract]   [Full Text] [Related]  

  • 36. Optic nerve involvement from Pseudomonas aeruginosa -associated skull base osteomyelitis.
    Winter TW; Anwar Z; Lam BL; Schatz NJ; Sternau LL; Guy JR
    JAMA Ophthalmol; 2013 Feb; 131(2):253-5. PubMed ID: 23411899
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
    Výmola F; Jedlicková Z
    Cesk Epidemiol Mikrobiol Imunol; 1972 Jul; 21(4):176-81. PubMed ID: 4262242
    [No Abstract]   [Full Text] [Related]  

  • 38. Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model.
    Xerri L; Broggio R; Guerra L
    Chemioterapia; 1986 Apr; 5(2):83-7. PubMed ID: 3085961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of ofloxacin in gynaecology.
    Petersen EE; de Isele TS; Pelz K; Weiss N
    Drugs; 1987; 34 Suppl 1():183-6. PubMed ID: 3481322
    [No Abstract]   [Full Text] [Related]  

  • 40. Subacute Osteomyelitis of the Symphysis Pubis After Left Oophoritis Caused by Pseudomonas Aeruginosa. A Case Report.
    Sllamniku S; Murtezani A; Haxhija EQ
    Ortop Traumatol Rehabil; 2024 Jun; 26(3):87-91. PubMed ID: 39374228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.